References
- Aebi, H., 1984. Catalase in vitro. Methods in Enzymology, 105, 121–126.
- Al Batran, R., et al., 2013. In vivo antioxidant and antiulcer activity of Parkia speciosa ethanolic leaf extract against ethanol-induced gastric ulcer in rats. PLoS One, 8 (5), e64751.
- Al-Harthi, S.E., et al., 2014. Amelioration of doxorubicin-induced cardiotoxicity by resveratrol. Molecular Medicine Reports, 10 (3), 1455–1460.
- Amic, D., et al., 2003. Structure-radical scavenging activity relationships of flavonoids. Croatica Chemica Acta, 76, 55–61.
- Bachur, N.R., et al., 1997. NADPH-cytochrome P450 reductase activation of quinone anticancer agents to free radicals. Proceeding of Natural Academy of Sciences, 76, 945–957.
- Bao, X.F., et al., 2002. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry, 59 (2), 175–181.
- Beuege, J.A. and Aust, S.D., 1978. Microsomal lipid peroxidation. Methods in Enzymology, 30, 302–310.
- Beutler, E., 1984. Red Cell Metabolism: A Manual of Biochemical Methods. 3rd ed. New York: Grune and Stratton.
- Chatterjee, K., et al., 2010. Doxorubicin cardiomyopathy. Cardiology, 115 (2), 155–162.
- Cherian, E., et al., 2009. Free-radical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (Curt: Fr) P. Karst and Arogyapacha-Trichopus zeylanicus Gaertn extracts. Journal of Basic and Clinical Physiology and Pharmacology, 20 (4), 289–307.
- Della-Torre, P., et al., 1994. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel. Cancer Chemotherapy and Pharmacology, 44, 138–142.
- Doroshow, J.H., 1983. Effect of anthracycline antibiotics on oxygen radicals formation in rat heart. Cancer Research, 43, 460–472.
- Ewer, M.S. and Ewer, S.M., 2010. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nature Reviews. Cardiology, 7 (10), 564–575.
- Fried, R., 1975. Enzymatic and non-enzymatic assay of superoxide dismutase. Biochimie, 57 (5), 657–660.
- Gao, S., et al., 2018. Meroterpenoids from Ganoderma sinense protect hepatocytes and cardiomyocytes from oxidative stress induced injuries. Fitoterapia, 131, 73–79.
- Gaschler, M.M. and Stockwell, B.R., 2017. Lipid peroxidation in cell death. Biochemical and Biophysical Research Communications, 482 (3), 419–425.
- Gutteridge, J.M.C., 1995. Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clinical Chemistry, 41 (12 Pt 2), 1819–1828.
- Hakkim, F.L., Al-Buloshi, M., and Achankunju, J., 2016. Chemical composition and anti-proliferative effect of Oman’s Ganoderma applanatum on breast cancer and cervical cancer cells. Journal of Taibah University Medical Sciences, 11 (2), 145–151.
- Halliwell, B. and Gutteridge, J. M., 1998. Free Radicals in Biology and Medicine. Oxford: Oxford University Press.
- Hamza, A.A., et al., 2016. Melissa officinalis protects against doxorubicin-induced cardiotoxicity in rats and potentiates its anticancer activity on MCF-7 cells. PLoS One, 11 (11), e0167049.
- Injac, R., et al., 2008. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60.OH. 24 via suppression of oxidative stress. Pharmacological Reports, 60, 742–749.
- Jeong, Y.T., et al., 2008. Ganoderma applanatum: a promising mushroom for antitumor and immunomodulating activity. Phytotherapy Research, 22 (5), 614–619.
- Jieqiong, M., et al., 2011. Cellular and molecular mechanisms of the Ganoderma applanatum extracts induces apoptosis on SGC-7901 gastric cancer cells. Cell Biochemistry and Function, 29 (3), 175–182.
- Jollow, D.J., et al., 1973. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. Journal of Pharmacology and Experimental Therapeutics, 187, 195–202.
- Kalyanaraman, B., et al., 2002. Doxorubicin-induced apoptosis: implications in cardiotoxicity. In: V. Vallyathan, X. Shi, and V. Castranova, eds. Oxygen/nitrogen radicals, cell injury and disease. Boston, MA: Springer, 119–124.
- Kimura, T., et al., 2000. Metallothionein acts as a cytoprotectant against doxorubicin toxicity. The Journal of Pharmacology and Experimental Therapeutics, 292 (1), 299–302.
- Leong, L.P. and Shui, G., 2002. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chemistry, 76 (1), 69–75.
- Li, T., et al., 2019. Protective effects of Ganoderma triterpenoids on cadmium-induced oxidative stress and inflammatory injury in chicken livers. Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS), 52, 118–125.
- Lipshultz, S.E., et al., 2013. Treatment-related cardiotoxicity in survivors of childhood cancer. Nature Reviews. Clinical Oncology, 10 (12), 697–710.
- LOWRY, O.H., et al., 1951. Protein measurement with the Folin-phenol reagent. The Journal of Biological Chemistry, 193 (1), 265–275.
- Luo, Q., et al., 2015. Applanatumin A, a new di-mericmeroterpenoid from Ganoderma applanatum that displays potent antifibrotic activity. ChemInform, 46 (29), no–1113.
- Minotti, G., et al., 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Reviews, 56 (2), 185–229.
- Mizuno, T., 1995. Bioactive biomolecules and mushrooms: food function and medicinal effects of mushroom fungi. Food Reviews International, 11 (1), 5–21.
- Mohajeri, M. and Sahebkar, A., 2018. Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Critical Reviews in Oncology/Hematology, 122, 30–51.
- Mohan, M., et al., 2010. Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and Chemical Toxicology, 48 (1), 436–440.
- Mohan, M., et al., 2011. Protective effect of Solanum torvum on Doxorubicin-induced hepatotoxicity in rats. International Journal of Drug Development and Research, 3, 131–138.
- Moradali, M.F., et al., 2006. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemotherapy, 52 (5), 241–244.
- Moron, M.S., Depierre, J.W., and Mannervik, B., 1979. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochimica et Biophysica Acta, 582 (1), 67–78.
- Myers, C., et al., 1983. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Seminars in Oncology, 10, 53–55.
- Octavia, Y., et al., 2012. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52 (6), 1213–1225.
- Ojha, S., et al., 2016. Cardioprotective potentials of plant-derived small molecules against doxorubicin associated cardiotoxicity. Oxidative Medicine and Cellular Longevity, 2016, 5724973.
- Oyaizu, M., 1986. Studies on product of browning reaction prepared from glucose amine. The Japanese Journal of Nutrition and Dietetics, 44 (6), 307–315.
- Rajasekaran, M. and Kalaimagal, C., 2012. Cardioprotective effect of a medicinal mushroom, Ganoderma lucidum against adriamycin induced toxicity. International Journal of Pharmacology, 8 (4), 252–254.
- Rajoriya, A., Tripathy, S.S., and Gupta, N., 2015. In vitro antioxidant activity of selected Ganoderma species found in Odisha, India. Tropical Plant Research, 2 (2), 72–77.
- Rashid, S., et al., 2013. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicology Mechanisms and Methods, 23 (5), 337–345.
- Re, R., et al., 1999. Antioxidant activity applying an improved ABTS radical cation-decolorization assay. Free Radical Biology & Medicine, 26 (9–10), 1231–1237.
- Rym, K.H., et al., 1999. Antiviral activity of water soluble substance from Elfvingia applanata. Korean Journal of Pharmacognosy, 30, 25–33.
- Sakanaka, S., Tachibana, Y., and Okada, Y., 2005. Preparation and antioxidant properties of extracts of Japanese persimmon leaf tea (kakinoha-cha). Food Chemistry, 89 (4), 569–575.
- Seifried, H. E., et al., 2006. New developments in antioxidant research. Happauge,NY: Nova science publishers.
- Singh, D.P., Verma, S., and Prabha, R., 2018. Investigations on antioxidant potential of phenolic acids and flavonoids: the common phytochemical ingredients in plants. Journal of Plant Biochemistry & Physiology, 06 (03), 3–10.
- Singleton, V.L. and Rossi, J.A., 1996. Calorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. American Journal of Enology and Viticulture, 16, 144–153.
- Smania, A.J., et al., 1999. Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. International Journal of Medicinal Mushrooms, 1 (4), 325–330.
- Stadtman, E.R., 1992. Protein oxidation and aging. Science (New York, N.Y.), 257 (5074), 1220–1224.
- Sudheesh, N.P., Ajith, T.A., and Janardhanan, K.K., 2013. Ganoderma lucidum ameliorate mitochondrial damage in isoproterenol-induced myocardial infarction in rats by enhancing the activities of TCA cycle enzymes and respiratory chain complexes. International Journal of Cardiology, 165 (1), 117–125.
- Takemura, G. and Fujiwara, H., 2007. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress in Cardiovascular Diseases, 49 (5), 330–352.
- Tan, C., et al., 1967. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease: clinical evaluation with special reference to childhood leukemia. Cancer, 20 (3), 333–353.
- Tiwari, A.K., 2001. Imbalance in antioxidant defence and human diseases: multiple approach of natural antioxidants therapy. Current Science, 81 (9), 1179–1187.
- Tokarska-Schlattner, M., et al., 2006. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. Journal of Molecular and Cellular Cardiology, 41 (3), 389–405.
- Veena, R.K., Ajith, T.A., and Janardhanan, K.K., 2018. Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), prevents doxorubicin-induced cardiotoxicity in rats. International Journal of Medicinal Mushrooms, 20 (8), 761–774.
- Wallace, K.B., 2003. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacology & Toxicology, 93 (3), 105–115.
- Wang, J., et al., 2017. Emerging roles of Ganoderma lucidum in anti-aging. Aging and Disease, 8 (6), 691–707.
- Wang, M.Y., et al., 2000. Effects of triterpenoids from Ganoderma lucidum (leyss. Ex fr.) karst on three different experimental liver injury models in mice. Acta Pharmacologica Sinica, 35 (5), 326–329.
- Wang, M.Y., et al., 2002. Effects of total triterpenoids extract from Ganoderma lucidum (Curt: Fr.) P. Karst. (Reishi mushroom) on experimental liver injury models induced by carbon tetrachloride or D-Galactosamine in mice. International Journal of Medicinal Mushrooms, 4 (4), 6–342.
- Wang, G.-W. and Kang, Y.J., 1999. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. Journal of Pharmacology and Experimental Therapeutics, 288, 938–944.
- Wang, M.Y. and Lin, Z.B., 2000. Effects of triterpenoids from Ganoderma lucidum on immunological liver injury in vivo and in vitro. Chinese Pharmaceutical Journal, 35, 809.
- Wasser, S.P., 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60 (3), 258–274.
- Weiss, R.B., 1992. The Anthracyclines: will we ever find a better doxorubicin. Seminars in Oncology, 19, 670–686.
- Wu, H.-Y. and Kang, Y.J., 1998. Inhibition of buthioninesulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart. The Journal of Pharmacology and Experimental Therapeutics, 287 (2), 515–552.
- Yang, X.J., et al., 2006. In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World Journal of Gastroenterology, 12 (9), 1379–1385.
- Yilmaz, S., et al., 2006. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology, 218 (2–3), 164–171.
- Yin, H., Xu, L., and Porter, N.A., 2011. Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews, 111 (10), 5944–5972.
- Zhou, S., Palmeira, C.M., and Wallace, K.B., 2001. Doxorubicin-induced persistent oxidative stress to cardiacmyocytes. Toxicology Letters, 121 (3), 151–157.